CD4 and neoplasm: Following depletion of either CD4+ (Extended Data Fig. 4a) or CD8+ (Extended Data Fig. 5a) T cells in SFB-colonized, B16-3340 tumor-bearing mice, there was a significant loss in the efficacy of anti-PD-1 treatment (Extended Data Fig. 4b and Extended Data Fig. 5b).